Hiroyuki Kouji

Hiroyuki Kouji

Auto-generated profile, based on publicly available information

Hiroyuki Kouji

Translational Chemical Biology Laboratory, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
HKHaruki Kawase
Haruki Kawase
YAYukio Ago
Yukio Ago
MNMegumi Naito
Megumi Naito
MHMomoko Higuchi
Momoko Higuchi
YHYuta Hara
Yuta Hara
HHHitoshi Hashimoto
Hitoshi Hashimoto

1 January 2019 in Annals of Dermatology
Verified
Journal Article
Open access
HMHaruna Matsuda-Hirose
Haruna Matsuda-Hirose
TYTomoko Yamate
Tomoko Yamate
MGMizuki Goto
Mizuki Goto
AKAkira Katoh
Akira Katoh
HKHiroyuki Kouji
Hiroyuki Kouji
YHYutaka Hatano
Yutaka Hatano
The canonical Wnt/β-catenin signaling pathway is a fundamental regulatory system involved in various biological events. ICG-001 selectively blocks the interaction of β-catenin with its transcriptional co-activator cyclic AMP response element-binding protein (CBP). Recent studies have provided convincing evidence of the inhibitory effects of ICG-001 on Wnt-driven disease models, such as organ fibrosis, cancer, acute lymphoblastic leukemia, and asthma. However, the effects of ICG-001 in atopic dermatitis (AD) have not been investigated. To investigate whether β-catenin/CBP-dependent signaling was contributed in the pathogenesis of AD and ICG-001 could be a therapeutic agent for AD. We examined the effects of ICG-001 in an AD-like murine model generated by repeated topical application of the hapten, oxazolone (Ox). ICG-001 or vehicle alone was injected intraperitoneally every day during the development of AD-like dermatitis arising from once-daily Ox treatment. Ox-induced AD-like dermatitis characterized by increases in transepidermal water loss, epidermal thickness, dermal thickness accompanied by increased myofibroblast and mast cell counts, and serum levels of thymic stromal lymphopoietin and thymus and activation-regulated chemokine, and decreases in stratum corneum hydration, were virtually normalized by the treatment with ICG-001. Elevated serum levels of periostin tended to be downregulated, without statistical significance. These results suggest that β-catenin/CBP-dependent signaling might be involved in the pathogenesis of AD and could be a therapeutic target.

1 July 2006 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
TOTakenao Odagami
Takenao Odagami
YTYuko Tsuda
Yuko Tsuda
YKYuji Kogami
Yuji Kogami
HKHiroyuki Kouji
Hiroyuki Kouji
YOYoshio Okada
Yoshio Okada

1 January 2009 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
TOTakenao Odagami
Takenao Odagami
YTYuko Tsuda
Yuko Tsuda
YKYuji Kogami
Yuji Kogami
HKHiroyuki Kouji
Hiroyuki Kouji
YOYoshio Okada
Yoshio Okada
The deprotection of the indole (Nind)-formyl (For) group on Trp was achieved in a 95% yield using N,N′-dimethylethylendiamine (DMEDA) (1.5, 2.0, 3.0 eq) in water at room temperature. A new reagent was successfully applied to the deprotection of a model peptide, H-Phe-Trp(Nind-For)-Lys-Tyr-OH, to give H-Phe-Trp-Lys-Tyr-OH in a 91% yield.

2 February 2022 in Heliyon
Verified
Journal Article
Open access
TDTomomitsu Doi
Tomomitsu Doi
HHHironori Hojo
Hironori Hojo
SOShinsuke Ohba
Shinsuke Ohba
KOKunie Obayashi
Kunie Obayashi
MEMotoyoshi Endo
Motoyoshi Endo
HKHiroyuki Kouji
Hiroyuki Kouji
Wnt/β-catenin is believed to regulate different sets of genes with different coactivators, cAMP response element-binding protein (CREB)-binding protein (CBP) or p300. However, the factors that determine which coactivators act on a particular promoter remain elusive. ICG-001 is a specific inhibitor for β-catenin/CBP but not for β-catenin/p300. By taking advantage of the action of ICG-001, we sought to investigate regulatory mechanisms underlying β-catenin coactivator usage in human pancreatic carcinoma PANC-1 cells through combinatorial analysis of chromatin immunoprecipitation-sequencing and RNA-sequencing. CBP and p300 preferentially bound to regions with the TCF motif alone and with both the TCF and AP-1 motifs, respectively. ICG-001 increased β-catenin binding to regions with both the TCF and AP-1 motifs, flanking the genes induced by ICG-001, concomitant with the increments of the p300 and AP-1 component c-JUN binding. Taken together, AP-1 possibly coordinates β-catenin coactivator usage in PANC-1 cells. These results would further our understanding of the canonical Wnt/β-catenin signaling divergence.